Related Experiment Videos
Comparative genomic hybridization and its application to Wilms' tumorigenesis
M E Getman1, T W Houseal, G A Miller
1Department of Human Genetics, Genzyme Corporation, Framingham, MA (USA). mgetman@rics.bwh.harvard.edu
Cytogenetics and Cell Genetics
|December 22, 1998
Summary
Comparative genomic hybridization (CGH) revealed chromosomal abnormalities in 20% of sporadic Wilms tumor samples. These genetic alterations, including gains and losses on various chromosomes, offer insights into Wilms tumor development.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Wilms tumor is a pediatric kidney cancer with complex genetic underpinnings.
- Identifying specific chromosomal aberrations is crucial for understanding disease etiology and progression.
Purpose of the Study:
- To investigate chromosomal alterations in sporadic Wilms tumor using comparative genomic hybridization (CGH).
- To identify novel genetic regions potentially involved in Wilms tumorigenesis.
Main Methods:
- Analysis of eighty sporadic Wilms tumor samples.
- Application of comparative genomic hybridization (CGH) for detecting chromosomal gains and losses.
Main Results:
- Twenty percent of samples exhibited chromosomal gains or losses.
- Common alterations included gains on chromosomes 1q, 7q, 8, 12 and losses on 1p, 4p, 4q, 7p, 16q, 18q, 21q, 22q.
- Novel deletions on 5p, 15q and gains on 3p, 3q were identified, suggesting new genes in Wilms tumor development.
Conclusions:
- CGH is effective in identifying chromosomal aberrations in Wilms tumors.
- Specific chromosomal regions, particularly 3p and 3q, may harbor genes critical for Wilms tumorigenesis.
- Further research into these novel regions could reveal new therapeutic targets.